通过nsp13酶抑制,重新利用万科米辛作为一种潜在的抗病毒药物来对抗PEDV
Qiao Chen1,2, Mengqi Yu1,2, Jiajing Guo1,2
1Joint International Research Laboratory of Animal Health and Food Safety of Ministry of Education, Nanjing Agricultural University, Nanjing 210095, China.
Animals : an open access journal from MDPI
|April 12, 2025
概括
抗菌药物万科米辛 (Vancomycin) 通过抑制猪流行性腹病毒 (PEDV) 的复制,显示出作为一种新型抗病毒药物的潜力. 这项研究确定了万科米辛作为PEDV nsp13的一个有前途的抑制剂,这是一个关键的病毒酶.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 生物化学 生化学
背景情况:
- 猪流行性腹病毒 (PEDV) 由于其高度传染性,在猪业中造成重大经济损失.
- 病毒螺旋酶,非结构蛋白13 (nsp13),对于PEDV复制至关重要,并代表抗病毒疗法的潜在目标.
研究的目的:
- 通过虚拟查来识别PEDV nsp13的潜在抑制剂.
- 为了研究万科米对PEDV的抗病毒活性.
- 为了阐明万科米辛抑制PEDV nsp13的机制.
主要方法:
- 虚拟查和分子动力学模拟以确定潜在的候选药物.
- 在体外生化分析以确认PEDV nsp13 NTPase和RNA酶活动.
- 在体外实验中评估万科米辛对PEDV nsp13和PEDV复制的抑制作用.
主要成果:
- 范科米辛表现出对PEDV nsp13.的稳定结合亲和力.
- 范科米辛在体外有效抑制了PEDV nsp13的酶活性.
- 范科米辛在体外显著降低了PEDV感染.
结论:
- 范科米辛被确定为PEDV nsp13的新型抑制剂,为PEDV提供了潜在的治疗策略.
- 这些发现提供了关于万科米辛对PEDV的抗病毒作用的机制性见解.
- 进一步的体内研究是有必要的,以评估万科米辛在治疗PEDV感染中的安全性和有效性.
相关概念视频
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


